Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer
- Registration Number
- NCT03906357
- Lead Sponsor
- Incyte Corporation
- Brief Summary
Expanded access of Pemigatinib to treat a single patient with metastatic pancreatic cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Exclusion Criteria
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method